These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The roles of anthrax toxin in pathogenesis. Moayeri M; Leppla SH Curr Opin Microbiol; 2004 Feb; 7(1):19-24. PubMed ID: 15036135 [TBL] [Abstract][Full Text] [Related]
25. Identification of small molecule inhibitors of anthrax lethal factor. Panchal RG; Hermone AR; Nguyen TL; Wong TY; Schwarzenbacher R; Schmidt J; Lane D; McGrath C; Turk BE; Burnett J; Aman MJ; Little S; Sausville EA; Zaharevitz DW; Cantley LC; Liddington RC; Gussio R; Bavari S Nat Struct Mol Biol; 2004 Jan; 11(1):67-72. PubMed ID: 14718925 [TBL] [Abstract][Full Text] [Related]
26. Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R. Zai X; Zhang J; Liu J; Liu J; Li L; Yin Y; Fu L; Xu J; Chen W Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26927174 [TBL] [Abstract][Full Text] [Related]
27. Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions. Koehler SM; Buyuk F; Celebi O; Demiraslan H; Doganay M; Sahin M; Moehring J; Ndumnego OC; Otlu S; van Heerden H; Beyer W BMC Vet Res; 2017 Jul; 13(1):220. PubMed ID: 28701192 [TBL] [Abstract][Full Text] [Related]
28. A dominant-negative therapy for anthrax. Leppla SH Nat Med; 2001 Jun; 7(6):659-60. PubMed ID: 11385497 [No Abstract] [Full Text] [Related]
29. Passive Immunotherapy Protects against Enteric Invasion and Lethal Sepsis in a Murine Model of Gastrointestinal Anthrax. Huang B; Xie T; Rotstein D; Fang H; Frucht DM Toxins (Basel); 2015 Sep; 7(10):3960-76. PubMed ID: 26426050 [TBL] [Abstract][Full Text] [Related]
30. Ratio of lethal and edema factors in rabbit systemic anthrax. Molin FD; Fasanella A; Simonato M; Garofolo G; Montecucco C; Tonello F Toxicon; 2008 Dec; 52(7):824-8. PubMed ID: 18812184 [TBL] [Abstract][Full Text] [Related]
31. [Infections by Bacillus anthracis]. Biederbick W; Fock R; Güttler K; Veit C Dtsch Med Wochenschr; 2002 Apr; 127(15):809-14. PubMed ID: 11951140 [No Abstract] [Full Text] [Related]
32. Transcriptional stimulation of anthrax toxin receptors by anthrax edema toxin and Bacillus anthracis Sterne spore. Xu Q; Hesek ED; Zeng M Microb Pathog; 2007 Jul; 43(1):37-45. PubMed ID: 17459655 [TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibody against the poly-gamma-D-glutamic acid capsule of Bacillus anthracis protects mice from enhanced lethal toxin activity due to capsule and anthrax spore challenge. Jang J; Cho M; Lee HR; Cha K; Chun JH; Hong KJ; Park J; Rhie GE Biochim Biophys Acta; 2013 Mar; 1830(3):2804-12. PubMed ID: 23201204 [TBL] [Abstract][Full Text] [Related]
36. Interactions between anthrax toxin receptors and protective antigen. Scobie HM; Young JA Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864 [TBL] [Abstract][Full Text] [Related]
37. Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracis. Cowan GJ; Atkins HS; Johnson LK; Titball RW; Mitchell TJ Vaccine; 2007 Oct; 25(41):7197-205. PubMed ID: 17765365 [TBL] [Abstract][Full Text] [Related]
38. Advances in the development of next-generation anthrax vaccines. Friedlander AM; Little SF Vaccine; 2009 Nov; 27 Suppl 4():D28-32. PubMed ID: 19837282 [TBL] [Abstract][Full Text] [Related]
39. Anthrax: clinical features, pathogenesis, and potential biological warfare threat. Friedlander AM Curr Clin Top Infect Dis; 2000; 20():335-49. PubMed ID: 10943532 [No Abstract] [Full Text] [Related]